Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Conmed (CNMD) Accumulated Depreciation & Amortization (2016 - 2025)

Conmed filings provide 16 years of Accumulated Depreciation & Amortization readings, the most recent being $316.6 million for Q4 2025.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 3.67% to $316.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $316.6 million, a 3.67% increase, with the full-year FY2025 number at $316.6 million, up 3.67% from a year prior.
  • Accumulated Depreciation & Amortization hit $316.6 million in Q4 2025 for Conmed, up from $305.4 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $316.6 million in Q4 2025 to a low of $263.8 million in Q4 2021.
  • Median Accumulated Depreciation & Amortization over the past 5 years was $292.2 million (2023), compared with a mean of $291.1 million.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: grew 7.22% in 2021 and later rose 3.67% in 2025.
  • Conmed's Accumulated Depreciation & Amortization stood at $263.8 million in 2021, then grew by 5.22% to $277.5 million in 2022, then rose by 5.27% to $292.2 million in 2023, then rose by 4.54% to $305.4 million in 2024, then increased by 3.67% to $316.6 million in 2025.
  • The last three reported values for Accumulated Depreciation & Amortization were $316.6 million (Q4 2025), $305.4 million (Q4 2024), and $292.2 million (Q4 2023) per Business Quant data.